JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for NEUROTECH PHARMACEUTICALS · pharmaceuticals

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Rhode Island · House · Senate · $10,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Issues related to approval of combination products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem